{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:36:29Z","timestamp":1792787789241,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82570690, No 82272624, No 81401985 and No. 31801113"],"award-info":[{"award-number":["No. 82570690, No 82272624, No 81401985 and No. 31801113"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"China Postdoctoral Science Foundation","award":["No.2018M632830, No.2020M670039ZX and No.2021M701793"],"award-info":[{"award-number":["No.2018M632830, No.2020M670039ZX and No.2021M701793"]}],"id":[{"id":"https:\/\/ror.org\/0426zh255","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Jiangsu Province","award":["No. BK20211105"],"award-info":[{"award-number":["No. BK20211105"]}]},{"name":"Social Development Foundation of Nantong City","award":["No. MS12021073, MS22022005, JCZ21061, JCZ20004, MS22022014"],"award-info":[{"award-number":["No. MS12021073, MS22022005, JCZ21061, JCZ20004, MS22022014"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-05076-x","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T05:33:03Z","timestamp":1784525583000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk factors and development of a predictive model for chronic kidney disease in patients with metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1186","volume":"26","author":[{"given":"Jiaojiao","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangpeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lishuai","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"5076_CR1","doi-asserted-by":"crossref","unstructured":"Huang DQ, Wong VWS, Rinella ME, et al. Metabolic dysfunction-associated steatotic liver disease in adults Nature reviews. Dis Prim. 2025;11(1):14.","DOI":"10.1038\/s41572-025-00599-1"},{"key":"5076_CR2","doi-asserted-by":"crossref","unstructured":"EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024;81(3):492\u2013542.","DOI":"10.1016\/j.jhep.2024.04.031"},{"key":"5076_CR3","doi-asserted-by":"crossref","unstructured":"Eslam M, Sanyal A J, George J. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease. Gastroenterol. 2020;158(7):1999\u20132014.e1.","DOI":"10.1053\/j.gastro.2019.11.312"},{"key":"5076_CR4","doi-asserted-by":"crossref","unstructured":"Eslam M, Newsome P N, Sarin S K, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020;73(1):202\u2013209.","DOI":"10.1016\/j.jhep.2020.07.045"},{"key":"5076_CR5","doi-asserted-by":"crossref","unstructured":"Mantovani A, Petracca G, Beatrice G, et al. Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis. Gut. 2022;71(1):156\u2013162.","DOI":"10.1136\/gutjnl-2020-323082"},{"issue":"5","key":"5076_CR6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","volume":"4","author":"J Li","year":"1999","unstructured":"Li J, Zou B, Yeo YH, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 1999;4(5):389\u201398.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"5076_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2023.101454","volume":"49","author":"GE Chung","year":"2023","unstructured":"Chung GE, Han K, Lee KN, et al. Association between fatty liver index and risk of end-stage renal disease stratified by kidney function in patients with type 2 diabetes: a nationwide population-based study. Diabetes Metab. 2023;49(4):101454.","journal-title":"Diabetes Metab"},{"key":"5076_CR8","doi-asserted-by":"crossref","unstructured":"Tanaka M, Mori K, Takahashi S, et al. Metabolic dysfunction-associated fatty liver disease predicts new onset of chronic kidney disease better than fatty liver or nonalcoholic fatty liver disease. Nephrol Dialysis Transplant. 2023;38(3):700\u2013711.","DOI":"10.1093\/ndt\/gfac188"},{"key":"5076_CR9","doi-asserted-by":"crossref","unstructured":"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (London, England). 2015;385(9963):117\u2013171.","DOI":"10.1016\/S0140-6736(14)61682-2"},{"key":"5076_CR10","unstructured":"Abbasi M A, Chertow G M, Hall Y N. End-stage renal disease. BMJ Clin Evidence. 2010;2010:2002."},{"key":"5076_CR11","unstructured":"Furth S L, Colhoun H M, Kanbay M, et al. The relationship between obesity and chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2025;S0085\u20132538(25)00774\u20134."},{"key":"5076_CR12","doi-asserted-by":"publisher","unstructured":"Marques M, Ortiz A, Romero-Gonz\u00e1lez G, et al. Ten hot topics in cardiovascular risk management for chronic kidney disease. Cardiorenal Med. 2026:1\u201334. https:\/\/doi.org\/10.1159\/000550943.","DOI":"10.1159\/000550943"},{"key":"5076_CR13","doi-asserted-by":"publisher","unstructured":"Schunk SJ, Zimmermann P. Cardiovascular Risk and Its Presentation in Chronic Kidney Disease. J Clin Med. 2025;14(13). https:\/\/doi.org\/10.3390\/JCM14134567.","DOI":"10.3390\/JCM14134567"},{"issue":"4","key":"5076_CR14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41581-021-00519-y","volume":"18","author":"TY Wang","year":"2022","unstructured":"Wang TY, Wang RF, Bu ZY, et al. Association of metabolic dysfunction-associated fatty liver disease with kidney disease. Nat Rev Nephrol. 2022;18(4):259\u201368.","journal-title":"Nat Rev Nephrol"},{"key":"5076_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26146962","author":"X Cao","year":"2025","unstructured":"Cao X, Wang N, Yang M, et al. Lipid accumulation and insulin resistance: bridging metabolic dysfunction-associated fatty liver disease and chronic kidney disease. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26146962.","journal-title":"Int J Mol Sci"},{"key":"5076_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1720780","volume":"16","author":"W Bai","year":"2025","unstructured":"Bai W, Zhu Z. Multiorgan crosstalk in MASLD\/MASH: from hepatic pathogenesis to systemic complications. Front Endocrinol. 2025;16:1720780.","journal-title":"Front Endocrinol"},{"key":"5076_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15101225","author":"S Alobaidi","year":"2025","unstructured":"Alobaidi S. Emerging biomarkers and advanced diagnostics in chronic kidney disease: early detection through multi-omics and AI. Diagnostics (Basel). 2025. https:\/\/doi.org\/10.3390\/diagnostics15101225.","journal-title":"Diagnostics (Basel)"},{"issue":"11","key":"5076_CR18","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.1007\/s11255-024-04103-8","volume":"56","author":"X Li","year":"1999","unstructured":"Li X, Wang L, Zhou H, et al. Association between triglyceride-glucose index and chronic kidney disease: results from NHANES 1999-2020. Int Urol Nephrol. 1999;56(11):3605\u201316.","journal-title":"Int Urol Nephrol"},{"issue":"12","key":"5076_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-066243","volume":"12","author":"Y Cheng","year":"2022","unstructured":"Cheng Y, Zhang H, Zheng H, et al. Association between serum uric acid\/HDL-cholesterol ratio and chronic kidney disease: a cross-sectional study based on a health check-up population. BMJ Open. 2022;12(12):e066243.","journal-title":"BMJ Open"},{"issue":"Suppl","key":"5076_CR20","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","volume":"31","author":"ZM Younossi","year":"2025","unstructured":"Younossi ZM, Kalligeros M, Henry L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol. 2025;31(Suppl):S32\u201350.","journal-title":"Clin Mol Hepatol"},{"key":"5076_CR21","doi-asserted-by":"crossref","unstructured":"Miller D M, McCauley K F, Dunham-Snary K J. Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Mechanisms, Clinical Implications and Therapeutic Advances. Endocrinol Diabetes Metabol. 2025;8(6):e70132.","DOI":"10.1002\/edm2.70132"},{"issue":"8","key":"5076_CR22","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s44411-025-00189-3","volume":"126","author":"K Lian","year":"2025","unstructured":"Lian K, Fan Q, Sheng S, et al. Metabolic Dysfunction-Associated Steatotic Liver Disease and Chronic Kidney Disease: Unraveling Connections and Advancing Therapies[J]. Bratislava Medical Journal. 2025;126(8):1573\u201388.","journal-title":"Bratislava Medical Journal"},{"issue":"10","key":"5076_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0334720","volume":"20","author":"Y Ono","year":"2025","unstructured":"Ono Y, Sakai K, Okamura T, et al. Metabolic dysfunction-associated steatotic liver disease (MASLD) can be a possible predictive factor of incident CKD: NAGALA cohort study. PLoS ONE. 2025;20(10):e0334720.","journal-title":"PLoS ONE"},{"issue":"1","key":"5076_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-024-03910-6","volume":"25","author":"W Liu","year":"2024","unstructured":"Liu W, Sun X. Does metabolic dysfunction-associated fatty liver disease increase the risk of chronic kidney disease? A meta-analysis of cohort studies. BMC Nephrol. 2024;25(1):467.","journal-title":"BMC Nephrol"},{"key":"5076_CR25","doi-asserted-by":"crossref","unstructured":"Bilson J, Mantovani A, Byrne C D, et al. Steatotic liver disease, MASLD and risk of chronic kidney disease. Diabetes Metabol. 2024;50(1):101506.","DOI":"10.1016\/j.diabet.2023.101506"},{"key":"5076_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/nu15010112","author":"S Liao","year":"2022","unstructured":"Liao S, Lin D, Feng Q, et al. Lipid parameters and the development of chronic kidney disease: a prospective cohort study in middle-aged and elderly Chinese individuals. Nutrients. 2022. https:\/\/doi.org\/10.3390\/nu15010112.","journal-title":"Nutrients"},{"key":"5076_CR27","doi-asserted-by":"crossref","unstructured":"Wang B, Li L, Tang Y, et al. Changes in non-high-density lipoprotein to high-density lipoprotein ratio (NHHR) and cardiovascular disease: insights from CHARLS. Lipids Health Dis. 2025;24(1):112.","DOI":"10.1186\/s12944-025-02536-3"},{"key":"5076_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/nu17071125","author":"X Chen","year":"2025","unstructured":"Chen X, Liang M, Zhang J, et al. The non-high-density lipoprotein cholesterol (Non-HDL-C) to HDL-C ratio (NHHR) and its association with chronic kidney disease in Chinese adults with type 2 diabetes: a preliminary study. Nutrients. 2025. https:\/\/doi.org\/10.3390\/nu17071125.","journal-title":"Nutrients"},{"key":"5076_CR29","doi-asserted-by":"crossref","unstructured":"Noels H, Lehrke M, Vanholder R, et al. Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations. Nat Rev Nephrol. 2021;17(8):528\u2013542.","DOI":"10.1038\/s41581-021-00423-5"},{"key":"5076_CR30","doi-asserted-by":"crossref","unstructured":"Fan Y Q, Wang H, Wang P P, et al. The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio as a predictive indicator of CKD risk in NAFLD patients: NHANES 2017\u20132020. Front Nutr. 2024;11:1501494.","DOI":"10.3389\/fnut.2024.1501494"},{"key":"5076_CR31","doi-asserted-by":"crossref","unstructured":"Rinella M E, Lazarus J V, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Annals Hepatol. 2024;29(1):101133.","DOI":"10.1016\/j.aohep.2024.101485"},{"key":"5076_CR32","doi-asserted-by":"crossref","unstructured":"Wang S, Chen R, Liu Q, et al. Prevalence, awareness and treatment of chronic kidney disease among middle-aged and elderly: The China Health and Retirement Longitudinal Study. Nephrology (Carlton, Vic.). 2015;20(7):474\u2013484.","DOI":"10.1111\/nep.12449"},{"key":"5076_CR33","doi-asserted-by":"crossref","unstructured":"Stevens L A, Claybon M A, Schmid C H, et al. Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. Kidney Int. 2011;79(5):555\u2013562.","DOI":"10.1038\/ki.2010.462"},{"key":"5076_CR34","doi-asserted-by":"crossref","unstructured":"Simental-Mend\u00eda L E, Rodr\u00edguez-Mor\u00e1n M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metabol Syndrome Relate Disord. 2008;6(4):299\u2013304.","DOI":"10.1089\/met.2008.0034"},{"key":"5076_CR35","doi-asserted-by":"crossref","unstructured":"Yang Y, Zhang J, Jia L, et al. Uric acid to high-density lipoprotein cholesterol ratio predicts adverse cardiovascular events in patients with coronary chronic total occlusion. Nutr Metabol Cardiovasc Dis. 2023;33(12):2471\u20132478.","DOI":"10.1016\/j.numecd.2023.07.037"},{"key":"5076_CR36","doi-asserted-by":"crossref","unstructured":"Wang Z, Wu M, Du R, et al. The relationship between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and hyperuricaemia.[J]. Lipids in health and disease, 2024;23(1):187.","DOI":"10.1186\/s12944-024-02171-4"},{"key":"5076_CR37","doi-asserted-by":"crossref","unstructured":"Lemeshow S, Hosmer D W J. A review of goodness of fit statistics for use in the development of logistic regression models. American journal of epidemiology. 1982;115(1):92\u2013106.","DOI":"10.1093\/oxfordjournals.aje.a113284"},{"key":"5076_CR38","doi-asserted-by":"crossref","unstructured":"Hanley J A, McNeil B J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143(1):29\u201336.","DOI":"10.1148\/radiology.143.1.7063747"},{"key":"5076_CR39","doi-asserted-by":"publisher","unstructured":"Calzadilla Bertot L, Adams L A. The Natural Course of Non-Alcoholic Fatty Liver Disease. Int J Mol Sci. 2016;17(5). https:\/\/doi.org\/10.1002\/(SICI)1097-0258(19960229)15:4%3C;361::AID-SIM168%3E;3.0.CO;2-4.","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4%3C;361::AID-SIM168%3E;3.0.CO;2-4"},{"key":"5076_CR40","doi-asserted-by":"crossref","unstructured":"Hagstr\u00f6m H, Shang Y, Hegmar H, et al. Natural history and progression of metabolic dysfunction-associated steatotic liver disease. Lancet Gastroenterol Hepatol. 2024;9(10):944\u2013956.","DOI":"10.1016\/S2468-1253(24)00193-6"},{"key":"5076_CR41","doi-asserted-by":"crossref","unstructured":"Miao L, Targher G, Byrne C D, et al. Current status and future trends of the global burden of MASLD. Trend Endocrinol Metabol. 2024;35(8):697\u2013707.","DOI":"10.1016\/j.tem.2024.02.007"},{"key":"5076_CR42","doi-asserted-by":"crossref","unstructured":"Targher G, Tilg H, Byrne C D. Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach. Lancet Gastroenterol Hepatology. 2021;6(7):578\u2013588.","DOI":"10.1016\/S2468-1253(21)00020-0"},{"key":"5076_CR43","doi-asserted-by":"crossref","unstructured":"Sun D Q, Targher G, Byrne C D, et al. An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease. Hepatobiliary Surgery Nutr. 2023;12(3):386\u2013403.","DOI":"10.21037\/hbsn-22-421"},{"key":"5076_CR44","doi-asserted-by":"crossref","unstructured":"Bertram J F, Hoy W E. Ageing: Nephron loss in the ageing kidney - it's more than you think. Nat Rev Nephrol. 2016;12(10):585\u2013586.","DOI":"10.1038\/nrneph.2016.130"},{"key":"5076_CR45","doi-asserted-by":"crossref","unstructured":"Denic A, Glassock R J, Rule A D. Structural and Functional Changes With the Aging Kidney. Adv Chronic Kidney Dis. 2016;23(1):19\u201328.","DOI":"10.1053\/j.ackd.2015.08.004"},{"issue":"1","key":"5076_CR46","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJM199601043340103","volume":"334","author":"MJ Klag","year":"1996","unstructured":"Klag MJ, Whelton PK, Randall BL, et al. Blood pressure and end-stage renal disease in men. N Engl J Med. 1996;334(1):13\u20138.","journal-title":"N Engl J Med"},{"key":"5076_CR47","doi-asserted-by":"crossref","unstructured":"KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int. 2021;99(3S):S1-S87.","DOI":"10.1016\/j.kint.2020.11.003"},{"issue":"2","key":"5076_CR48","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1681\/ASN.2004080656","volume":"16","author":"P Muntner","year":"2005","unstructured":"Muntner P, He J, Astor BC, et al. Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study. J Am Soc Nephrol. 2005;16(2):529\u201338.","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"5076_CR49","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMra041809","volume":"352","author":"G Weiss","year":"2005","unstructured":"Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352(10):1011\u201323.","journal-title":"N Engl J Med"},{"issue":"12","key":"5076_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2025.101589","volume":"7","author":"O Masrour","year":"2025","unstructured":"Masrour O, Ehrhard F, Guillaume M, et al. Diagnostic accuracy of transient elastography in MASLD is independent of MRI-PDFF steatosis in a multicenter study. JHEP Reports. 2025;7(12):101589.","journal-title":"JHEP Reports"},{"issue":"4","key":"5076_CR51","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"FEJ Harrell","year":"1996","unstructured":"Harrell FEJ, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15(4):361\u201387.","journal-title":"Stat Med"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-05076-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05076-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05076-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:51:44Z","timestamp":1791982304000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-05076-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5076"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-05076-x","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"25 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the Affiliated Hospital of Nantong University. All patients provided written informed consent for the use of their clinical data for research purposes at the time of their health check-up or hospital admission. The Ethics Committee waived the requirement for additional informed consent for this retrospective analysis of anonymized data.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"642"}}